Prescription drug · UNAPPROVED DRUG OTHER
Np Thyroid (Levothyroxine, liothyronine) NDC 72189-218
Liothyronine 4.5 ug/1; Levothyroxine 19 ug/1 · Tablet · Oral · DIRECT RX
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72189-218-90 | 72189021890 | 90 TABLET in 1 BOTTLE (72189-218-90)Marketed from May 11, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Np Thyroid
- Generic name (nonproprietary)
- levothyroxine, liothyronine
- Active ingredients
- Liothyronine — 4.5 ug/1Levothyroxine — 19 ug/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- DIRECT RXNDC labeler code 72189
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Thyroxine (Chemical structure)Triiodothyronine (Chemical structure)
- Identifiers
- Product ID 72189-218_2c283f9f-1db7-4a4c-e063-6394a90a7953SPL ID 2c283f9f-1db7-4a4c-e063-6394a90a7953SPL set ID c20f4ab2-8dbd-b83f-e053-2995a90a52dbRxCUI 313387, 313391, 1724439, 1724481UNII Q51BO43MG4, 06LU7C9H1V
- Pharmacologic class
- l-Thyroxine; l-Triiodothyronine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472189021890followed by a unit qualifier and the quantityPackage 72189-0218-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE: NP Thyroid tablets (thyroid tablets, USP) are indicated: 1. As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. This category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism (See WAR…
Excerpt only. Read the full label for complete information.
About NDC 72189-218
- What is NDC 72189-218?
- 72189-218 is the product NDC for Np Thyroid, Liothyronine 4.5 ug/1; Levothyroxine 19 ug/1 tablet, listed with the FDA by DIRECT RX. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Np Thyroid (Levothyroxine, liothyronine).
- What is the active ingredient?
- Liothyronine, Levothyroxine.
- Who is the labeler?
- DIRECT RX, NDC labeler code 72189. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Np Thyroid?
- 15 other product NDCs are listed under this name. See all Np Thyroid NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Np Thyroid products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| NP Thyroidthyroid tablets | Liothyronine 4.5 ug/1; Levothyroxine 19 ug/1 | TabletOral | Calvin Scott & Co Inc. | 17224-502 | 17224-0502-28 |
| NP Thyroidthyroid tablets | Liothyronine 4.5 ug/1; Levothyroxine 19 ug/1 | TabletOral | Calvin Scott & Co Inc. | 17224-502 | 17224-0502-30 |
| NP Thyroidthyroid tablets | Liothyronine 4.5 ug/1; Levothyroxine 19 ug/1 | TabletOral | Calvin Scott & Co Inc. | 17224-502 | 17224-0502-60 |
| NP Thyroidthyroid tablets | Levothyroxine 38 ug/1; Liothyronine 9 ug/1 | TabletOral | Calvin Scott & Co Inc. | 17224-503 | 17224-0503-28 |
| NP Thyroidthyroid tablets | Liothyronine 9 ug/1; Levothyroxine 38 ug/1 | TabletOral | Calvin Scott & Co Inc. | 17224-503 | 17224-0503-30 |
| NP Thyroidthyroid tablets | Liothyronine 9 ug/1; Levothyroxine 38 ug/1 | TabletOral | Calvin Scott & Co Inc. | 17224-503 | 17224-0503-60 |
| NP Thyroidthyroid tablets | Liothyronine 13.5 ug/1; Levothyroxine 57 ug/1 | TabletOral | Calvin Scott & Co Inc. | 17224-504 | 17224-0504-28 |
| NP Thyroidthyroid tablets | Levothyroxine 57 ug/1; Liothyronine 13.5 ug/1 | TabletOral | Calvin Scott & Co Inc. | 17224-504 | 17224-0504-30 |
| NP Thyroidthyroid tablets | Levothyroxine 57 ug/1; Liothyronine 13.5 ug/1 | TabletOral | Calvin Scott & Co Inc. | 17224-504 | 17224-0504-60 |
| NP Thyroidthyroid tablets | Liothyronine 18 ug/1; Levothyroxine 76 ug/1 | TabletOral | Calvin Scott & Co Inc. | 17224-505 | 17224-0505-60 |